1. Home
  2. IMRN vs ANY Comparison

IMRN vs ANY Comparison

Compare IMRN & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • ANY
  • Stock Information
  • Founded
  • IMRN 1994
  • ANY N/A
  • Country
  • IMRN Australia
  • ANY United States
  • Employees
  • IMRN N/A
  • ANY N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • IMRN Health Care
  • ANY Finance
  • Exchange
  • IMRN Nasdaq
  • ANY Nasdaq
  • Market Cap
  • IMRN 14.4M
  • ANY 23.8M
  • IPO Year
  • IMRN N/A
  • ANY N/A
  • Fundamental
  • Price
  • IMRN $1.70
  • ANY $0.63
  • Analyst Decision
  • IMRN
  • ANY Strong Buy
  • Analyst Count
  • IMRN 0
  • ANY 1
  • Target Price
  • IMRN N/A
  • ANY $3.00
  • AVG Volume (30 Days)
  • IMRN 84.8K
  • ANY 1.2M
  • Earning Date
  • IMRN 08-29-2025
  • ANY 11-12-2025
  • Dividend Yield
  • IMRN N/A
  • ANY N/A
  • EPS Growth
  • IMRN N/A
  • ANY N/A
  • EPS
  • IMRN N/A
  • ANY N/A
  • Revenue
  • IMRN $4,777,422.00
  • ANY $10,831,000.00
  • Revenue This Year
  • IMRN N/A
  • ANY N/A
  • Revenue Next Year
  • IMRN N/A
  • ANY $36.07
  • P/E Ratio
  • IMRN N/A
  • ANY N/A
  • Revenue Growth
  • IMRN 48.63
  • ANY N/A
  • 52 Week Low
  • IMRN $1.50
  • ANY $0.36
  • 52 Week High
  • IMRN $2.48
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 32.32
  • ANY 36.78
  • Support Level
  • IMRN $1.80
  • ANY $0.68
  • Resistance Level
  • IMRN $1.99
  • ANY $0.75
  • Average True Range (ATR)
  • IMRN 0.14
  • ANY 0.10
  • MACD
  • IMRN -0.06
  • ANY -0.03
  • Stochastic Oscillator
  • IMRN 17.50
  • ANY 2.33

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: